BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 33527979)

  • 21. The frequency of B- and T-cell gene rearrangements and epstein-barr virus in T-cell lymphomas: a comparison between angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified with and without associated B-cell proliferations.
    Tan BT; Warnke RA; Arber DA
    J Mol Diagn; 2006 Sep; 8(4):466-75; quiz 527. PubMed ID: 16931587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathological features of programmed cell death-1 and programmed cell death-ligand-1 expression in the tumor cells and tumor microenvironment of angioimmunoblastic T cell lymphoma and peripheral T cell lymphoma not otherwise specified.
    Kim S; Kwon D; Koh J; Nam SJ; Kim YA; Kim TM; Kim CW; Jeon YK
    Virchows Arch; 2020 Jul; 477(1):131-142. PubMed ID: 32170448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct morphologic, phenotypic, and clinical-course characteristics of indolent peripheral T-cell lymphoma.
    Hayashi E; Takata K; Sato Y; Tashiro Y; Tachiyama Y; Sawada-Kitamura S; Hiramatsu Y; Sugiguchi S; Nose S; Hirokawa M; Ando M; Abd Alkader L; Maeda Y; Tanimoto M; Yoshino T
    Hum Pathol; 2013 Sep; 44(9):1927-36. PubMed ID: 23706909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peripheral T-cell lymphoma with progression to a clonally related, Epstein Barr virus+, cytotoxic aggressive T-cell lymphoma: evidence for secondary EBV infection of an established malignant T-cell clone.
    Langer R; Geissinger E; RĂ¼diger T; von Schilling C; Ott G; Mandl-Weber S; Quintanilla-Martinez L; Fend F
    Am J Surg Pathol; 2010 Sep; 34(9):1382-7. PubMed ID: 20739840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study.
    Piccaluga PP; Fuligni F; De Leo A; Bertuzzi C; Rossi M; Bacci F; Sabattini E; Agostinelli C; Gazzola A; Laginestra MA; Mannu C; Sapienza MR; Hartmann S; Hansmann ML; Piva R; Iqbal J; Chan JC; Weisenburger D; Vose JM; Bellei M; Federico M; Inghirami G; Zinzani PL; Pileri SA
    J Clin Oncol; 2013 Aug; 31(24):3019-25. PubMed ID: 23857971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathobiology of nodal peripheral T-cell lymphomas: current understanding and future directions.
    Bisig B; Savage KJ; De Leval L
    Haematologica; 2023 Dec; 108(12):3227-3243. PubMed ID: 38037800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The aggressive peripheral T-cell lymphomas: 2013.
    Armitage JO
    Am J Hematol; 2013 Oct; 88(10):910-8. PubMed ID: 24078271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Classification and diagnostic evaluation of nodal T- and NK-cell lymphomas.
    Feldman AL; Laurent C; Narbaitz M; Nakamura S; Chan WC; de Leval L; Gaulard P
    Virchows Arch; 2023 Jan; 482(1):265-279. PubMed ID: 36210383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.
    Kanavaros P; Boulland ML; Petit B; Arnulf B; Gaulard P
    Leuk Lymphoma; 2000 Jul; 38(3-4):317-26. PubMed ID: 10830738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Epstein-Barr Virus on Peripheral T-Cell Lymphoma Not Otherwise Specified and Angioimmunoblastic T-Cell Lymphoma.
    Kim TY; Min GJ; Jeon YW; Park SS; Park S; Shin SH; Yahng SA; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Lee JW; Cho SG
    Front Oncol; 2021; 11():797028. PubMed ID: 35087758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current Concepts in Nodal Peripheral T-Cell Lymphomas.
    Oishi N; Feldman AL
    Surg Pathol Clin; 2023 Jun; 16(2):267-285. PubMed ID: 37149360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive analysis of clinical, pathological, and genomic characteristics of follicular helper T-cell derived lymphomas.
    Yoon SE; Cho J; Kim YJ; Ko YH; Park WY; Kim SJ; Kim WS
    Exp Hematol Oncol; 2021 May; 10(1):33. PubMed ID: 33990228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: Report from COMPLETE, a prospective, multicenter cohort study.
    Park SI; Horwitz SM; Foss FM; Pinter-Brown LC; Carson KR; Rosen ST; Pro B; Hsi ED; Federico M; Gisselbrecht C; Schwartz M; Bellm LA; Acosta M; Advani RH; Feldman T; Lechowicz MJ; Smith SM; Lansigan F; Tulpule A; Craig MD; Greer JP; Kahl BS; Leach JW; Morganstein N; Casulo C; Shustov AR;
    Cancer; 2019 May; 125(9):1507-1517. PubMed ID: 30694529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral T-cell lymphoma with Reed-Sternberg-like cells of B-cell phenotype and genotype associated with Epstein-Barr virus infection.
    Quintanilla-Martinez L; Fend F; Moguel LR; Spilove L; Beaty MW; Kingma DW; Raffeld M; Jaffe ES
    Am J Surg Pathol; 1999 Oct; 23(10):1233-40. PubMed ID: 10524524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Profiling of peripheral T-cell lymphomas in Kerala, South India: A 5-year study.
    Nair RA; Vasudevan JA; Jacob PM; Sukumaran R
    Indian J Pathol Microbiol; 2017; 60(2):206-208. PubMed ID: 28631636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Follicular peripheral T-cell lymphoma expands the spectrum of classical Hodgkin lymphoma mimics.
    Moroch J; Copie-Bergman C; de Leval L; Plonquet A; Martin-Garcia N; Delfau-Larue MH; Molinier-Frenkel V; Belhadj K; Haioun C; Audouin J; Swerdlow SH; Marafioti T; Gaulard P
    Am J Surg Pathol; 2012 Nov; 36(11):1636-46. PubMed ID: 23073322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The aggressive peripheral T-cell lymphomas: 2012 update on diagnosis, risk stratification, and management.
    Armitage JO
    Am J Hematol; 2012 May; 87(5):511-9. PubMed ID: 22508369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy.
    Abramson JS; Feldman T; Kroll-Desrosiers AR; Muffly LS; Winer E; Flowers CR; Lansigan F; Nabhan C; Nastoupil LJ; Nath R; Goy A; Castillo JJ; Jagadeesh D; Woda B; Rosen ST; Smith SM; Evens AM
    Ann Oncol; 2014 Nov; 25(11):2211-2217. PubMed ID: 25193992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Small cell variant of peripheral T-cell lymphoma, not otherwise specified: a clinicopathologic and immunophenotypic analysis].
    Li YL; Liu WP; Tang Y; Zhao S; Zuo Z; Yang YH; Yang QP; Luo TY
    Zhonghua Bing Li Xue Za Zhi; 2009 May; 38(5):323-8. PubMed ID: 19575875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of Angioimmunoblastic T-Cell Lymphoma (AITL) and other T Follicular Helper Cell lymphomas (TFH PTCL).
    Ma H; O'Connor OA; Marchi E
    Semin Hematol; 2021 Apr; 58(2):95-102. PubMed ID: 33906727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.